This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, diarrhea, and constipation. These should get better with time. Avoid fatty ...
Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...
Older adults taking semaglutide drugs such as Ozempic and Wegovy are quitting treatment at roughly twice the rate of younger ...
The new Wegovy pill is causing a buzz as more people look for alternatives to weight loss injections, but like all ...
Semaglutide is the active ingredient in several U.S. Food and Drug Administration (FDA)-approved treatment options for ...
Over 4,400 lawsuits target Ozempic and GLP-1 drugs for GI injuries, vision loss, and "Ozempic face." Usage stats, shortages, ...
A pharmacist has warned that patients interested in the new Wegovy pill may not be getting the full picture on the strict ...
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...
Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid ...
Add Yahoo as a preferred source to see more of our stories on Google. Dramatic drops in the risk of cancer and heart problems have been associated with weight loss drugs, but so have digestive ...